Howard Hughes Medical Institute’s Illumina ILMN Stock Holding History

Howard Hughes Medical Institute’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-586	Closed	-$97K	–	165
2017 Q1	$97K	Buy	+586	New	+$92.3K	0.02%	138
2016 Q1	–	Sell	-2,409	Closed	-$450K	–	180
2015 Q4	$450K	Sell	2,409 -4,598	-66%	-$742K	0.07%	103
2015 Q3	$1.2M	Sell	7,007 -5,844	-45%	-$1.18M	0.22%	61
2015 Q2	$2.73M	Sell	12,851 -1,285	-9%	-$251K	0.58%	43
2015 Q1	$2.55M	Buy	14,136 +5,146	+57%	+$969K	0.35%	48
2014 Q4	$1.61M	Buy	8,990 +2,754	+44%	+$485K	0.43%	53
2014 Q3	$994K	Buy	6,236 +2,883	+86%	+$482K	0.22%	54
2014 Q2	$582K	Buy	+3,353	New	+$500K	0.1%	52

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Howard Hughes Medical Institute's ILMN Position: Q2 2017 in Review

Howard Hughes Medical Institute sold out of Illumina (ILMN) in Q2 2017, closing a stake of 586 shares — an estimated $97K sold.

Howard Hughes Medical Institute first reported a position in ILMN in Q2 2014 and held it in 8 quarters. The position peaked at $2.73M in Q2 2015. 564 funds tracked by Wall St. Rank hold ILMN as of Q2 2017.

Howard Hughes Medical Institute reported no remaining Illumina position as of Q2 2017 after selling out during the quarter.
Howard Hughes Medical Institute sold 586 Illumina shares in Q2 2017, an estimated $97K.
Howard Hughes Medical Institute first reported a position in Illumina in Q2 2014 and held it in 8 quarters.
Howard Hughes Medical Institute's Illumina position peaked at $2.73M in Q2 2015.
564 funds tracked by Wall St. Rank held Illumina as of Q2 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2017, filed 11 Aug 2017.